Status:
COMPLETED
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
Lead Sponsor:
University of California, San Diego
Conditions:
Sleep Initiation and Maintenance Disorders
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will: * improve sle...
Detailed Description
Pain and fatigue are the most common symptom complaints of cancer patients. Although dramatic improvements have come about in recognizing and treating cancer related pain, less progress has been made ...
Eligibility Criteria
Inclusion
- Male or female patients hospitalized for chemotherapy or blood/bone marrow transplant.
- Age 20 - 75
- Not currently regularly taking any prescribed sleeping pill more often than 4x/week.
- Can tolerate oral medication.
Exclusion
- Patients with a current history of substance abuse
- Patients with a history of allergic response to Lunesta.
- Patient who require additional oral or parenteral opioids after starting PCA opioid treatment.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00365261
Start Date
September 1 2006
End Date
December 1 2009
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Thornton Hospital
La Jolla, California, United States, 92037